|
The Food and Drug Administration has green-lighted ViiV Healthcare’s Rukobia (fostemsavir).
The medication offers a new antiretroviral treatment for adults living with HIV who have tried multiple HIV medications and whose HIV infection cannot be successfully treated with other therapies because of resistance, intolerance or safety considerations.
|